271 related articles for article (PubMed ID: 19519329)
1. Recent developments of in silico predictions of intestinal absorption and oral bioavailability.
Hou T; Li Y; Zhang W; Wang J
Comb Chem High Throughput Screen; 2009 Jun; 12(5):497-506. PubMed ID: 19519329
[TBL] [Abstract][Full Text] [Related]
2. Recent developments of in silico predictions of oral bioavailability.
Zhu J; Wang J; Yu H; Li Y; Hou T
Comb Chem High Throughput Screen; 2011 Jun; 14(5):362-74. PubMed ID: 21470180
[TBL] [Abstract][Full Text] [Related]
3. Structure-ADME relationship: still a long way to go?
Hou T; Wang J
Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):759-70. PubMed ID: 18611116
[TBL] [Abstract][Full Text] [Related]
4. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model.
Paixão P; Gouveia LF; Morais JA
Int J Pharm; 2012 Jun; 429(1-2):84-98. PubMed ID: 22449410
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Human Intestinal Absorption of Compounds Using Artificial Intelligence Techniques.
Kumar R; Sharma A; Siddiqui MH; Tiwari RK
Curr Drug Discov Technol; 2017; 14(4):244-254. PubMed ID: 28382857
[TBL] [Abstract][Full Text] [Related]
7. Gaussian processes for classification: QSAR modeling of ADMET and target activity.
Obrezanova O; Segall MD
J Chem Inf Model; 2010 Jun; 50(6):1053-61. PubMed ID: 20433177
[TBL] [Abstract][Full Text] [Related]
8. The survey of the use of QSAR methods to determine intestinal absorption and oral bioavailability during drug design.
Silva FT; Trossini GH
Med Chem; 2014; 10(5):441-8. PubMed ID: 24730584
[TBL] [Abstract][Full Text] [Related]
9. [Recent advance in predicting oral bioavailability].
Ma GL; Cheng YY
Yao Xue Xue Bao; 2006 Oct; 41(10):917-20. PubMed ID: 17184106
[No Abstract] [Full Text] [Related]
10. ADME evaluation in drug discovery. 8. The prediction of human intestinal absorption by a support vector machine.
Hou T; Wang J; Li Y
J Chem Inf Model; 2007; 47(6):2408-15. PubMed ID: 17929911
[TBL] [Abstract][Full Text] [Related]
11. Computational modeling of human oral bioavailability: what will be next?
Cabrera-Pérez MÁ; Pham-The H
Expert Opin Drug Discov; 2018 Jun; 13(6):509-521. PubMed ID: 29663836
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Oral Bioavailability in Rats: Transferring Insights from in Vitro Correlations to (Deep) Machine Learning Models Using in Silico Model Outputs and Chemical Structure Parameters.
Schneckener S; Grimbs S; Hey J; Menz S; Osmers M; Schaper S; Hillisch A; Göller AH
J Chem Inf Model; 2019 Nov; 59(11):4893-4905. PubMed ID: 31714067
[TBL] [Abstract][Full Text] [Related]
13. Predicting the impact of physiological and biochemical processes on oral drug bioavailability.
Agoram B; Woltosz WS; Bolger MB
Adv Drug Deliv Rev; 2001 Oct; 50 Suppl 1():S41-67. PubMed ID: 11576695
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo and in situ approaches used to study intestinal absorption.
Luo Z; Liu Y; Zhao B; Tang M; Dong H; Zhang L; Lv B; Wei L
J Pharmacol Toxicol Methods; 2013; 68(2):208-216. PubMed ID: 23831587
[TBL] [Abstract][Full Text] [Related]
15. Artificial Intelligence-Based Quantitative Structure-Property Relationship Model for Predicting Human Intestinal Absorption of Compounds with Serotonergic Activity.
Czub N; Szlęk J; Pacławski A; Klimończyk K; Puccetti M; Mendyk A
Mol Pharm; 2023 May; 20(5):2545-2555. PubMed ID: 37070956
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors.
Zhao YH; Le J; Abraham MH; Hersey A; Eddershaw PJ; Luscombe CN; Butina D; Beck G; Sherborne B; Cooper I; Platts JA
J Pharm Sci; 2001 Jun; 90(6):749-84. PubMed ID: 11357178
[TBL] [Abstract][Full Text] [Related]
17. Improving on in-silico prediction of oral drug bioavailability.
Alqahtani S
Expert Opin Drug Metab Toxicol; 2023; 19(10):665-670. PubMed ID: 37728393
[TBL] [Abstract][Full Text] [Related]
18. In silico drug absorption tract: An agent-based biomimetic model for human oral drug absorption.
Deng J; Jhandey A; Zhu X; Yang Z; Yik KFP; Zuo Z; Lam TN
PLoS One; 2018; 13(8):e0203361. PubMed ID: 30169515
[TBL] [Abstract][Full Text] [Related]
19. pH-permeability profiles for drug substances: Experimental detection, comparison with human intestinal absorption and modelling.
Oja M; Maran U
Eur J Pharm Sci; 2018 Oct; 123():429-440. PubMed ID: 30100533
[TBL] [Abstract][Full Text] [Related]
20. An update on the potential role of intestinal first-pass metabolism for the prediction of drug-drug interactions: the role of PBPK modeling.
Alqahtani S; Bukhari I; Albassam A; Alenazi M
Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):625-634. PubMed ID: 29806951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
